5 results
diagnosis rheumatology sle activation antinxp2dm comparison druginduced erythematosus hematology macrophage mas monkeypox summary syndrome systemic table
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
40, F:M 9:1 • Clinical ... Manifestations: Malar rash ... - pANCA anti-MPO ... life-threatening • Treatment ... Evolution: Chronic disease
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... NPSLE rare, Malar rash ... - pANCA anti-MPO ... Manifestations: Malar rash ... Evolution: Chronic disease
Monkeypox What? Monkeypox virus belongs to the family Poxviridae, subfamily Chordopoxvirinae, and genus orthopoxvirus Viral zoonotic disease that is
Viral zoonotic disease ... Characteristic Rash ... Umbilification - Rash ... three weeks Clinical ... #Dermatology
Anti-NXP-2 Dermatomyositis What? DM with generalized subcutaneous edema Pts have more myalgias, more severe weakness, and an increased prevalence
(blue-purple) rash ... • Erythematous rash ... had more severe disease ... #AntiNXP2 #Dermatomyositis ... #diagnosis #management
Macrophage Activation Syndrome (MAS) Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH) What? A subset of
• Systemic lupus ... Petechial or purpuric rash ... SJIA], systemic lupus ... Treatment: • Corticosteroids ... Syndrome #Diagnosis #Management
No results found for "CRASH clinical ocular dermatology ultrasound dermatomyositis rash physicalexam disease treatment antinxp2 management mpox lupus"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #CRASH #clinical #ocular #dermatology #ultrasound #dermatomyositis #rash #physicalexam #disease #treatment #antinxp2 #management #mpox #lupus